@article{APS5948,
author = {Alireza Mohajjel Nayebi and Seyedreza Pourrabi and Seyedebrahim Hossini},
title = {Testosterone ameliorates streptozotocin-induced memory impairment in male rats},
journal = {Acta Pharmacologica Sinica},
volume = {35},
number = {6},
year = {2016},
keywords = {},
abstract = {Alireza Mohajjel NAYEBI1, Seyedreza POURRABI2, *, Seyedebrahim HOSSINI3
1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 51664, Iran; 2Department of Biology, Science and Research Branch, Islamic Azad University, Fars, Iran; 3Department of Biology, Science and Research Branch, Islamic Azad University, Fars, Iran
Aim: To study the effects of testosterone on streptozotocin (STZ)-induced memory impairment in male rats.
Methods: Adult male Wistar rats were intracerebroventricularly (icv) infused with STZ (750 µg) on d 1 and d 3, and a passive avoidance task was assessed 2 weeks after the first injection of STZ. Castration surgery was performed in another group of rats, and the passive avoidance task was assessed 4 weeks after the operation. Testosterone (1 mg·kg-1·d-1, sc), the androgen receptor antagonist flutamide (10 mg·kg-1·d-1, ip), the estrogen receptor antagonist tamoxifen (1 mg·kg-1·d-1, ip) or the aromatase inhibitor letrozole (4 mg·kg-1·d-1, ip) were administered for 6 d after the first injection of STZ.
Results: STZ administration and castration markedly decreased both STL1 (the short memory) and STL2 (the long memory) in passive avoidance tests. Testosterone replacement almost restored the STL1 and STL2 in castrated rats, and significantly prolonged the STL1 and STL2 in STZ-treated rats. Administration of flutamide, letrozole or tamoxifen significantly impaired the memory in intact rats, and significantly attenuated the testosterone replacement in improving STZ- and castration-induced memory impairment.
Conclusion: Testosterone administration ameliorates STZ- and castration-induced memory impairment in male Wistar rats.
Keywords: learning and memory; streptozotocin; testosterone; flutamide; letrozole; tamoxifen; Alzheimer’s disease
We wish to thank the Director of the Drug Applied Research Center and the Research Vice-Chancellor, Tabriz University of Medical Sciences for supporting this study.
* To whom correspondence should be addressed.
E-mail pourrabie@gmail.com
Received 2013-07-27 Accepted 2014-01-21},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/5948}
}